Functions and Control of the Pulmonary Circulation

Pulmonary Vascular Disease

Volumn , Issue , 2006, Pages 1-19

  Mazza, Emilio ^a   Taichman, Darren ^b,c,d  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b Medical Intensive Care Unit   (United States)

^c PENN PRESBYTERIAN MEDICAL CENTER   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 70349674865     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4160-2246-6.50007-9     Document Type: Chapter

References (131)

1. A Hislop and L Reid (1973) Pulmonary arterial development during childhood: Branching pattern and structure. Thorax 28 129-135.
2. JB Howell, S Permutt, DF Proctor, et al. (1961) Effect of inflation of the lung on different parts of pulmonary vascular bed. J Appl Physiol 16 71-76.
3. DY Rosenzweig, JM Hughes and JB Glazier (1970) Effects of transpulmonary and vascular pressures on pulmonary blood volume in isolated lung. J Appl Physiol 28 553-560.
4. S Koyama, WJ Lamm, J Hildebrandt, et al. (1989) Flow characteristics of open vessels in zone 1 rabbit lungs. J Appl Physiol 66 1817-1823.
5. B Meyrick and L Reid (1983) Pulmonary hypertension. Anatomic and physiologic correlates. Clin Chest Med 4 199-217.
6. J Gil and D Ciurea (1996) Functional structure of the pulmonary circulation. AJ Peacock (Eds) Pulmonary circulation: A handbook for clinicians London: Chapman and Hall Medical 1-11.
7. ER Weibel (1997) Design and morphometry of the pulmonary gas exchanger. RG Crystal, JB West, ER Weibel, et al., (Eds) The lung: Scientific foundations Philadelphia: Lippincott-Raven 1147-1157.
8. K Tsukimoto, O Mathieu-Costello, R Prediletto, et al. (1991) Ultrastructural appearances of pulmonary capillaries at high transmural pressures. J Appl Physiol 71 573-582.
9. JB West, CT Dollery and A Naimark (1964) Distribution of blood flow in isolated lung; relation to vascular and alveolar pressures. J Appl Physiol 19 713-724.
10. F Wiener, E Morkin, R Skalak, et al. (1966) Wave propagation in the pulmonary circulation. Circ Res 19 834-850.
11. JM Hughes, JB Glazier, JE Maloney, et al. (1968) Effect of lung volume on the distribution of pulmonary blood flow in man. Respir Physiol 4 58-72.
12. J Bhattacharya and NC Staub (1980) Direct measurement of microvascular pressures in the isolated perfused dog lung. Science 210 327-328.
13. JS Brody, EJ Stemmler and AB DuBois (1968) Longitudinal distribution of vascular resistance in the pulmonary arteries, capillaries, and veins. J Clin Invest 47 783-799.
14. HJ Swan, W Ganz, J Forrester, et al. (1970) Catheterization of the heart in man with use of a flow-directed balloon-tipped catheter. N Engl J Med 283 447-451.
15. JF Murray, RB Karp and JA Nadel (1969) Viscosity effects on pressure-flow relations and vascular resistance in dogs' lungs. J Appl Physiol 27 336-341.
16. HG Borst, M McGregor, JL Whittenberger, et al. (1956) Influence of pulmonary arterial and left atrial pressures on pulmonary vascular resistance. Circ Res 4 393-399.
17. AP Fishman (1985) Handbook of physiology, Sec. 3: The respiratory system: Circulation and nonrespiratory functions. AP Fishman, AB Fishman (Eds) Pulmonary circulation 1 Bethesda: American Physiological Society 93-166.
18. A Roos, LJ Thomas Jr, EL Nagel, et al. (1961) Pulmonary vascular resistance as determined by lung inflation and vascular pressures. J Appl Physiol 16 77-84.
19. JB Glazier, JM Hughes, JE Maloney, et al. (1969) Measurements of capillary dimensions and blood volume in rapidly frozen lungs. J Appl Physiol 26 65-76.
20. RW Mazzone, CM Durand and JB West (1978) Electron microscopy of lung rapidly frozen under controlled physiological conditions. J Appl Physiol 45 325-333.
21. JB West, CT Dollery and BE Heard (1965) Increased pulmonary vascular resistance in the dependent zone of the isolated dog lung caused by perivascular edema. Circ Res 17 191-206.
22. US Von Euler and G Liljestrand (1946) Observations on the pulmonary arterial blood pressure in the cat. Acta Physiol Scan 12 301-320.
23. AB Malik and BS Kidd (1973) Independent effects of changes in H + and CO concentrations on hypoxic pulmonary vasoconstriction. J Appl Physiol 34 318-323.
24. LJ Rubin and JD Lazar (1983) Nonadrenergic effects of isopro-terenol in dogs with hypoxic pulmonary vasoconstriction. Possible role of prostaglandins. J Clin Invest 71 1366-1374.
25. M Unger, M Atkins, WA Briscoe, et al. (1977) Potentiation of pulmonary vasoconstrictor response with repeated intermittent hypoxia. J Appl Physiol 43 662-667.
26. M Kato and NC Staub (1966) Response of small pulmonary arteries to unilobar hypoxia and hypercapnia. Circ Res 19 426-440.
27. P Harris and D Heath (1986) Influences of respiratory gases. P Harris, D Heath (Eds) The human pulmonary circulation London: Churchill-Livingston 456-483.
28. Y Zhao, CS Packer and RA Rhoades (1993) Pulmonary vein contracts in response to hypoxia. Am J Physiol 265 L87-L92.
29. SL Archer, JM Huang, HL Reeve, et al. (1996) Differential distribution of electrophysiologically distinct myocytes in conduit and resistance arteries determines their response to nitric oxide and hypoxia. Circ Res 78 431-442.
30. J Lopez-Barneo, JR Lopez-Lopez, J Urena, et al. (1988) Chemotransduction in the carotid body: K +current modulated by PO in type I chemoreceptor cells. Science 241 580-582.
31. JM Post, JR Hume, SL Archer, et al. (1992) Direct role for potassium channel inhibition in hypoxic pulmonary vasoconstriction. Am J Physiol 262 C882-C890.
32. XJ Yuan, WF Goldman, ML Tod, et al. (1993) Hypoxia reduces potassium currents in cultured rat pulmonary but not mesenteric arterial myocytes. Am J Physiol 264 L116-L123.
33. SL Archer, E Souil, AT Dinh-Xuan, et al. (1998) Molecular identification of the role of voltage-gated K +channels, Kv1.5 and Kv2.1, in hypoxic pulmonary vasoconstriction and control of resting membrane potential in rat pulmonary artery myocytes. J Clin Invest 101 2319-2330.
34. SL Archer, B London, V Hampl, et al. (2001) Impairment of hypoxic pulmonary vasoconstriction in mice lacking the voltage-gated potassium channel Kv1.5. FASEB J 15 1801-1803.
35. IF McMurtry, AB Davidson, JT Reeves, et al. (1976) Inhibition of hypoxic pulmonary vasoconstriction by calcium antagonists in isolated rat lungs. Circ Res 38 99-104.
36. A Franco-Obregon and J Lopez-Barneo (1996) Differential oxygen sensitivity of calcium channels in rabbit smooth muscle cells of conduit and resistance pulmonary arteries. J Physiol 491(Pt 2), 511–518
37. S Archer and E Michelakis (2002) The mechanism(s) of hypoxic pulmonary vasoconstriction: Potassium channels, redox O( 2) sensors, and controversies. News Physiol Sci 17 131-137.
38. AM Rudolph and S Yuan (1966) Response of the pulmonary vasculature to hypoxia and H +ion concentration changes. J Clin Invest 45 399-411.
39. C Marshall, L Lindgren and BE Marshall (1984) Metabolic and respiratory hydrogen ion effects on hypoxic pulmonary vasoconstriction. J Appl Physiol 57 545-550.
40. M Dumas, JP Dumas, L Rochette, et al. (1996) Comparison of the effects of nicorandil, pinacidil and nitroglycerin on hypoxic and hypercapnic pulmonary vasoconstriction in the isolated perfused lung of rat. Br J Pharmacol 117 633-638.
41. T Yamaguchi, RF O'Brien, WL Hanson, et al. (1989) Prostacyclin contributes to inhibition of hypoxic pulmonary vasoconstriction by alkalosis. Prostaglandins 38 53-63.
42. SF Liu, DE Crawley, PJ Barnes, et al. (1991) Endothelium-derived relaxing factor inhibits hypoxic pulmonary vasoconstriction in rats. Am Rev Respir Dis 143 32-37.
43. L Zhao, DE Crawley, JM Hughes, et al. (1993) Endothelium-derived relaxing factor activity in rat lung during hypoxic pulmonary vascular remodeling. J Appl Physiol 74 1061-1065.
44. W Steudel, M Scherrer-Crosbie, KD Bloch, et al. (1998) Sustained pulmonary hypertension and right ventricular hypertrophy after chronic hypoxia in mice with congenital deficiency of nitric oxide synthase 3. J Clin Invest 101 2468-2477.
45. T Morita, MA Perrella, ME Lee, et al. (1995) Smooth muscle cell-derived carbon monoxide is a regulator of vascular cGMP. Proc Nati Acad Sci U S A 92 1475-1479.
46. H Christou, T Morita, CM Hsieh, et al. (2000) Prevention of hypoxia-induced pulmonary hypertension by enhancement of endogenous heme oxygenase-1 in the rat. Circ Res 86 1224-1229.
47. SJ Stanford, MJ Walters, AA Hislop, et al. (2003) Heme oxygenase is expressed in human pulmonary artery smooth muscle where carbon monoxide has an anti-proliferative role. Eur J Pharmacol 473 135-141.
48. S Berkor (1974) Hypoxic pulmonary vasoconstriction in the rat. The necessary role of angiotensin II. Circ Res 35 256-261.
49. NW Morrell, KG Morris and KR Stenmark (1995) Role of angiotensin-converting enzyme and angiotensin II in development of hypoxic pulmonary hypertension. Am J Physiol 269 H1186-H1194.
50. JP Szidon and JF Flint (1977) Significance of sympathetic innervation of pulmonary vessels in response to acute hypoxia. J Appl Physiol 43 65-71.
51. ED Robin, J Theodore, CM Burke, et al. (1987) Hypoxic pulmonary vasoconstriction persists in the human transplanted lung. Clin Sci (Land) 72 283-287.
52. LJ Ignarro, RE Byrns, GM Buga, et al. (1987) Mechanisms of endothelium-dependent vascular smooth muscle relaxation elicited by bradykinin and VIP. Am J Physiol 253 H1074-H1082.
53. JS Stamler, E Loh, MA Roddy, et al. (1994) Nitric oxide regulates basal systemic and pulmonary vascular resistance in healthy humans. Circulation 89 2035-2040.
54. W Steudel, F Ichinose, PL Huang, et al. (1997) Pulmonary vasoconstriction and hypertension in mice with targeted disruption of the endothelial nitric oxide synthase (NOS3) gene. Circ Res 81 34-41.
55. M Yanagisawa, H Kurihara, S Kimura, et al. (1988) A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332 411-415.
56. B Seo, BS Oemar, R Siebenmann, et al. (1994) Both ETA and ETB receptors mediate contraction to endothelin-1 in human blood vessels. Circulation 89 1203-1208.
57. DM Pollock, TL Keith and RF Highsmith (1995) Endothelin receptors and calcium signaling. FASEB J 9 1196-1204.
58. Y Hirata, T Emori, S Eguchi, et al. (1993) Endothelin receptor subtype B mediates synthesis of nitric oxide by cultured bovine endothelial cells. J Clin Invest 91 1367-1373.
59. M Clozel, V Breu, GA Gray, et al. (1993) In vivo pharmacology of Ro 46–2005, the first synthetic nonpeptide endothelin receptor antagonist: implications for endothelin physiology. J Cardiovasc Pharmacol 22(Suppl 8), S377-S379.
60. N Galie, A Manes and A Branzi (2004) The endothelin system in pulmonary arterial hypertension. Cardiovasc Res 61 227-237.
61. W Johnson, A Nohria, L Garrett, et al. (2002) Contribution of endothelin to pulmonary vascular tone under normoxic and hypoxic conditions. Am J Physiol Heart Circ Physiol 283 H568-H575.
62. N Davie, SJ Haleen, PD Upton, et al. (2002) ET(A) and ET(B) receptors modulate the proliferation of human pulmonary artery smooth muscle cells. Am J Respir Crit Care Med 165 398-405.
63. P de Lagausie, A de Buys-Roessingh, L Ferkdadji, et al. (2005) Endothelin receptor expression in human lungs of newborns with congenital diaphragmatic hernia. J Pathol 205 112-118.
64. M Bauer, H Wilkens, F Langer, et al. (2002) Selective upregulation of endothelin B receptor gene expression in severe pulmonary hypertension. Circulation 105 1034-1036.
65. DJ Abraham, R Vancheeswaran, MR Dashwood, et al. (1997) Increased levels of endothelin-1 and differential endothelin type A and B receptor expression in scleroderma-associated fibrotic lung disease. Am J Pathol 151 831-841.
66. NF Voelkel, JG Gerber, IF McMurtry, et al. (1981) Release of vasodilator prostaglandin, PGI 2, from isolated rat lung during vasoconstriction. Circ Res 48 207-213.
67. C Michiels, T Arnould, I Knott, et al. (1993) Stimulation of prostaglandin synthesis by human endothelial cells exposed to hypoxia. Am J Physiol 264 C866-C874.
68. MW Geraci, B Gao, DC Shepherd, et al. (1999) Pulmonary prostacyclin synthase overexpression in transgenic mice protects against development of hypoxic pulmonary hypertension. J Clin Invest 103 1509-1515.
69. RM Tuder, CD Cool, MW Geraci, et al. (1999) Prostacyclin synthase expression is decreased in lungs from patients with severe pulmonary hypertension. Am J Respir Crit Care Med 159 1925-1932.
70. RJ Barst, LJ Rubin, WA Long, et al. (1996) A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension. The Primary Pulmonary Hypertension Study Group. N Engl J Med 334 296-302.
71. VV McLaughlin, DE Genthner, MM Panella, et al. (1998) Reduction in pulmonary vascular resistance with long-term epoprostenol (prostacyclin) therapy in primary pulmonary hypertension. N Engl J Med 338 273-277.
72. HM Goll, DP Nyhan, HS Geller, et al. (1986) Pulmonary vascular responses to angiotensin II and captopril in conscious dogs. J Appl Physiol 61 1552-1559.
73. E Frantz, SJ Soifer, RI Clyman, et al. (1989) Bradykinin produces pulmonary vasodilation in fetal lambs: role of prostaglandin production. J Appl Physiol 67 1512-1517.
74. G Bönner, S Preis, U Schunk, et al. (1990) Hemodynamic effects of bradykinin on systemic and pulmonary circulation in healthy and hypertensive humans. J Cardiovasc Pharmacol 15(Suppl 6), S46-S56.
75. SL Archer, K Rist, DP Nelson, et al. (1990) Comparison of the hemodynamic effects of nitric oxide and endothelium-dependent vasodilators in intact lungs. J Appl Physiol 68 735-747.
76. DP Nyhan, HS Geller, HM Goll, et al. (1986) Pulmonary vasoactive effects of exogenous and endogenous AVP in conscious dogs. Am J Physiol 251 H1009-H1016.
77. BR Walker, J Haynes Jr, HL Wang, et al. (1989) Vasopressin-induced pulmonary vasodilation in rats. Am J Physiol 257 H415-H422.
78. HK Jin, RH Yang, YF Chen, et al. (1989) Hemodynamic effects of arginine vasopressin in rats adapted to chronic hypoxia. J Appl Physiol 66 151-160.
79. I Cigarini, S Adnot, PE Chabrier, et al. (1989) Pulmonary vasodilator responses to atrial natriuretic factor and sodium nitroprusside. J Appl Physiol 67 2269-2275.
80. NS Hill, JR Klinger, RR Warburton, et al. (1994) Brain natriuretic peptide: possible role in the modulation of hypoxic pulmonary hypertension. Am J Physiol 266 L308-L315.
81. P Wood (1959) Pulmonary hypertension with special reference to the vasoconstrictive factor. Br Heart J 21 557.
82. CO Feddersen, MM Mathias, IF McMurtry, et al. (1986) Acetylcholine induces vasodilation and prostacyclin synthesis in rat lungs. Prostaglandins 31 973-987.
83. SA Barman, E Senteno, S Smith, et al. (1989) Acetylcholine's effect on vascular resistance and compliance in the pulmonary circulation. J Appl Physiol 67 1495-1503.
84. T Ahmed, KB Mirbahar, W Oliver Jr, et al. (1982) Characterization of H1- and H2-receptor function in pulmonary and systemic circulations of sheep. J Appl Physiol 53 175-184.
85. PJ Kadowitz and AL Hyman (1983) Pulmonary vascular responses to histamine in sheep. Am J Physiol 244 H423-H428.
86. B Rippe, RC Allison, JC Parker, et al. (1984) Effects of histamine, serotonin, and norepinephrine on circulation of dog lungs. J Appl Physiol 57 223-232.
87. M Shirai, K Sada and I Ninomiya (1987) Nonuniform effects of histamine on small pulmonary vessels in cats. J Appl Physiol 62 451-458.
88. JS Brody and EJ Stemmler (1968) Differential reactivity in the pulmonary circulation. J Clin Invest 47 800-808.
89. JB Glazier and JF Murray (1971) Sites of pulmonary vasomotor reactivity in the dog during alveolar hypoxia and serotonin and histamine infusion. J Clin Invest 50 2550-2558.
90. SL Lee, WW Wang, JJ Lanzillo, et al. (1994) Serotonin produces both hyperplasia and hypertrophy of bovine pulmonary artery smooth muscle cells in culture. Am J Physiol 266 L46-L52.
91. BW Christman, CD McPherson, JH Newman, et al. (1992) An imbalance between the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension. N Engl J Med 327 70-75.
92. A Giaid, M Yanagisawa, D Langleben, et al. (1993) Expression of endothelin-1 in the lungs of patients with pulmonary hypertension. N Engl J Med 328 1732-1739.
93. S Morelli, C Ferri, E Polettini, et al. (1995) Plasma endothelin-1 levels, pulmonary hypertension, and lung fibrosis in patients with systemic sclerosis. Am J Med 99 255-260.
94. C Rubens, R Ewert, M Halank, et al. (2001) Big endothelin-1 and endothelin-1 plasma levels are correlated with the severity of primary pulmonary hypertension. Chest 120 1562-1569.
95. T Yamakami, O Taguchi, EC Gabazza, et al. (1997) Arterial endothelin-1 level in pulmonary emphysema and interstitial lung disease. Relation with pulmonary hypertension during exercise. Eur Respir J 10 2055-2060.
96. SF Liu and PJ Barnes (1997) Neural control of pulmonary vascular tone. RG Crystal, JB West (Eds) The lung: Scientific foundations Philadelphia: Lippincott-Raven 1457-1472.
97. PJ Kadowitz and AL Hyman (1973) Effect of sympathetic nerve stimulation on pulmonary vascular resistance in the dog. Circ Res 32 221-227.
98. J Boe and BG Simonsson (1980) Adrenergic receptors and sympathetic agents in isolated human pulmonary arteries. Eur J Respir Dis 61 195-202.
99. AL Hyman, HL Lippton and PJ Kadowitz (1990) Analysis of pulmonary vascular responses in cats to sympathetic nerve stimulation under elevated tone conditions. Evidence that neuronally released nor-epinephrine acts on alpha 1-, alpha 2-, and beta 2-adrenoceptors. Circ Res 67 862-870.
100. RJ Shebuski, T Fujita and RR Ruffolo Jr (1986) Evaluation of alpha-1 and alpha-2 adrenoceptor-mediated vasoconstriction in the in situ, autoperfused, pulmonary circulation of the anesthetized dog. J Pharmacol Exp Ther 238 217-223.
101. HN Duke and RD Stedford (1960) Pulmonary vasomotor responses to epinephrine and norepinephrine in the cat. Influence of the sympathetic nervous system. Circ Res 8 640-647.
102. SW Kabins, J Fridman, M Kandelman, et al. (1962) Effect of sympathectomy on pulmonary embolism-induced lung edema. Am J Physiol 202 687-689.
103. AB Malik (1985) Mechanisms of neurogenic pulmonary edema. Circ Res 57 1-18.
104. PW Clougherty, DP Nyhan, BB Chen, et al. (1988) Autonomic nervous system pulmonary vasoregulation after hypoperfusion in conscious dogs. Am J Physiol 254 H976-H983.
105. H Sakakibara, Y Hashiba, K Taki, et al. (1992) Effect of sympathetic nerve stimulation on lung vascular permeability in the rat. Am Rev Respir Dis 145 685-692.
106. WP Peterson, GA Trempy, K Nishiwaki, et al. (1993) Neurohumoral regulation of the pulmonary circulation during circulatory hypotension in conscious dogs. J Appl Physiol 75 1675-1682.
107. AL Hyman and PJ Kadowitz (1988) Tone-dependent responses to acetylcholine in the feline pulmonary vascular bed. J Appl Physiol 64 2002-2009.
108. B Greenberg, K Rhoden and PJ Barnes (1987) Endothelium-dependent relaxation of human pulmonary arteries. Am J Physiol 252 H434-H438.
109. TJ McMahon, JS Hood and PJ Kadowitz (1992) Pulmonary vasodilator response to vagal stimulation is blocked by N omega-nitro-L-arginine methyl ester in the cat. Circ Res 70 364-369.
110. DG McCormack, JC Mak, P Minette, et al. (1988) Muscarinic receptor subtypes mediating vaso-dilation in the pulmonary artery. Eur J Pharmacol 158 293-297.
111. HA el-Kashef, WF Hofman, IC Ehrhart, et al. (1991) Multiple muscarinic receptor subtypes in the canine pulmonary circulation. J Appl Physiol 71 2032-2043.
112. RJ Altiere, DC Travis, J Roberts, et al. (1994) Pharmacological characterization of muscarinic receptors mediating acetylcholine-induced contraction and relaxation in rabbit intrapulmonary arteries. J Pharmacol Exp Ther 270 269-276.
113. PA Murray, RF Lodato and JR Michael (1986) Neural antagonists modulate pulmonary vascular pressure-flow plots in conscious dogs. J Appl Physiol 60 1900-1907.
114. LB Wilson and MG Levitzky (1989) Chemoreflex blunting of hypoxic pulmonary vasoconstriction is vagally mediated. J Appl Physiol 66 782-791.
115. S Liu, HP Kuo, MN Sheppard, et al. (1994) Vagal stimulation induces increased pulmonary vascular permeability in guinea pig. Am J Respir Crit Care Med 149 744-750.
116. Y Hamasaki, M Mojarad and SI Said (1983) Relaxant action of VIP on cat pulmonary artery: Comparison with acetylcholine, isoproterenol, and PGE1. J Appl Physiol 54 1607-1611.
117. DG McCormack, JC Mak, MO Coupe, et al. (1989) Calcitonin gene-related peptide vasodilation of human pulmonary vessels. J Appl Physiol 67 1265-1270.
118. TJ McMahon and PJ Kadowitz (1993) Analysis of responses to substance P in the pulmonary vascular bed of the cat. Am J Physiol 264 H394-H402.
119. ES Silverman, ME Gerritsen, T Collins (1997) Metabolic functions of the pulmonary endothelium. RG Crystal, JB West, ER Weibel, et al., (Eds) The lung: Scientific foundations Philadelphia: Lippincott-Raven 629-651.
120. WW Carley, MJ Niedbala and ME Gerritsen (1992) Isolation, cultivation, and partial characterization of micro-vascular endothelium derived from human lung. Am J Respir Cell Mol Biol 7 620-630.
121. JD Pearson, JS Carleton, A Hutchings, et al. (1978) Uptake and metabolism of adenosine by pig aortic endothelial and smooth-muscle cells in culture. Biochem J 170 265-271.
122. Y Dieterle, C Ody, A Ehrensberger, et al. (1978) Metabolism and uptake of adenosine triphosphate and adenosine by porcine aortic and pulmonary endothelial cells and fibroblasts in culture. Circ Res 42 869-876.
123. SJ Gaba, D Bourgouin-Karaouni, P Dujols, et al. (1986) Effects of adenosine triphosphate on pulmonary circulation in chronic obstructive pulmonary disease. ATP: a pulmonary vasoregulator? Am Rev Respir Dis 134 1140-1144.
124. RH Steinhorn, FC Morin 3rd, DG Van Wylen, et al. (1994) Endothelium-dependent relaxations to adenosine in juvenile rabbit pulmonary arteries and veins. Am J Physiol 266 H2001-H2006.
125. JD Pearson, JS Carleton and JL Gordon (1980) Metabolism of adenine nucleotides by ectoenzymes of vascular endothelial and smooth-muscle cells in culture. Biochem J 190 421-429.
126. JH Gaddum, CO Hebb, A Silver, et al. (1953) 5-Hydroxytryptamine; pharmacological action and destruction in perfused lungs. Q J Exp Psychol 38 255-262.
127. A Fishman and G.G. Pietra (1974) Handling of bioactive materials by the lung. New Engl J Med 291 884-890.
128. BL Fanburg and JB Glazier (1973) Conversion of angiotensin 1 to angiotensin 2 in the isolated perfused dog lung. J Appl Physiol 35 325-331.
129. G de Nucci, R Thomas, P D'Orleans-Juste, et al. (1988) Pressor effects of circulating endothelin are limited by its removal in the pulmonary circulation and by the release of prostacyclin and endothelium-derived relaxing factor. Proc Natl Acad Sci U S A 85 9797-9800.
130. KA Hajjar, NM Hamel, PC Harpel, et al. (1987) Binding of tissue plasminogen activator to cultured human endothelial cells. J Clin Invest 80 1712-1719.
131. MP Bevilacqua, RR Schleef, MA Gimbrone Jr, et al. (1986) Regulation of the fibrinolytic system of cultured human vascular endothelium by interleukin 1. J Clin Invest 78 587-591.